Apiject

BFS technology allows for rapid scale-up with flexible production runs, a versatile supply chain, and versatile product development.

Any formulation is checked for compatibility in ApiJect’s container, where they look for a loss of potency and impurities compared to other containers that are used.

To meet the demand in the market, ApiJect is working with external supply chains for contract manufacturing.

Videos

ApiJect’s Strategy and Adaptation of BFS Technology

This blow-fill-seal (BFS) series continues with ApiJect’s Kendall Foster, who covers why BFS is such a consistent, reliable, and economical technique. 

Realizing the Advantages of Blow-Fill-Seal, Part Two

In part one of a two-part series on blow-fill-seal, Beth Totin of ApiJect discusses how innovative blow-fill-seal/pre-filled syringe (BFS/PFS) technology is becoming a competitive advantage in today’s marketplace. 

Realizing the Advantages of Blow-Fill-Seal, Part One

As global demand for prefilled syringes continues to increase, a new format is emerging that utilize blow-fill-seal (BFS) technology to meet the demand and provide a cost effective and safe way to deliver injectables to patients around the world. Advances in aseptic BFS have enabled an increasingly wide range of large molecules to be successfully filled and finished using BFS technology, making it suitable and qualified to handle most drug products. The reliability of BFS PFS and the availability of its materials in major markets offers companies a flexible, reliable, and robust supply chain even in challenging global environments.

Learn how this BFS technology can enable prefilled syringes to serve the entire injectables market.

Discuss project execution strategies and tactics employed to achieve the warp speed timeline.

Learn how BFS prefilled syringes enable a robust and resilient alternate supply chain.

Decision Makers, Director Level through C-Suite

For any questions please contact Kelsey Barry: kbarry@mjhlifesciences.com

Ray Guidotti comes to ApiJect with more than 30 years of pharma experience in global business, operational strategy and execution, supply chain management, manufacturing network design, and capital project planning and execution. From 2009 to 2020, he served in a variety of executive leadership roles with Patheon Pharmaceuticals and Thermo Fisher Scientific, which acquired Patheon in August 2017. Most recently he was Group vice president of global engineering, capacity planning, and technical/operations services for Pharma Services Group within Thermo Fisher Scientific, a global leader in serving science and an industry leader in contract pharmaceutical development and manufacturing services.

With more than 20 years of experience in marketing and business development, Beth Totin has spearheaded the growth of blow-fill-seal (BFS) and traditional glass filling (prefilled syringes, vials, and cartridge) manufacturing and commercialization efforts for several multinational contract manufacturing organizations. Prior to joining ApiJect, Beth was responsible for the introduction of a new manufacturing facility in North America for Unither Pharmaceuticals (France), significantly scaling the site for sterile and oral product technologies. During her time at Siegfried, Beth directed innovation efforts around biologics and delivery devices through domestic and international production sites of glass ampoules, vials, cartridges, and BFS. At Catalent, she expanded the customer base by helping to create a new injectable BFS product offering while overseeing a domestic BFS manufacturing site and multiple international sites serving global customers.


Director, Aseptic Technology
PS-Integrated Project Services

Rob Roy offers over 35 years of experience as a subject-matter expert in the engineering, qualification, and application of advanced aseptic technology for the pharmaceutical and biotechnology industries. He has technical expertise in barrier isolation technology, potent/BSL material handling and containment, cleaning validation, and CIP/SIP systems. Rob has served in senior management roles directing global engineering, design, and manufacturing teams on fast-track design/build/qualification activities for clinical and commercial scale aseptic fill/finish facilities.

Webcasts

Friday, June 24, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST

Apiject

Articles